Idiopathic immune-mediated hemolytic anemia: Treatment outcome and prognostic factors in 149 dogs

Journal of Veterinary Internal Medicine

Volumn 22, Issue 2, 2008, Pages 366-373

  Piek, C J ^a   Junius, G ^b   Dekker, A ^d   Schrauwen, E ^c   Slappendel, R J ^a   Teske, E ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b GHENT UNIVERSITY   (Belgium)

^c Dierenartsenpraktijk Plantijn   (Belgium)

^d WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Azathioprine; Prednisolone; Prognosis; Spherocytosis; Therapy

Indexed keywords

AZATHIOPRINE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ANIMAL; ANIMAL DISEASE; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD TRANSFUSION; COHORT ANALYSIS; DOG; DOG DISEASE; DRUG COMBINATION; FEMALE; FLUID THERAPY; IMMUNOLOGY; MALE; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANIMALS; AZATHIOPRINE; BLOOD TRANSFUSION; COHORT STUDIES; DOG DISEASES; DOGS; DRUG THERAPY, COMBINATION; FEMALE; FLUID THERAPY; GLUCOCORTICOIDS; IMMUNOSUPPRESSIVE AGENTS; MALE; PREDNISOLONE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 42449093775     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2008.0060.x     Document Type: Article

References (27)

1. Frank MM. Pathophysiology of immune hemolytic anemia. Ann Intern Med 1977;87:210-222.
2. Cotter S. Autoimmune hemolytic anemia. Compend Contin Educ Small Anim 1992;14:E93-E100.
3. Duval D, Giger U. Vaccine-associated immune-mediated hemolytic anemia in the dog. J Vet Intern Med 1996;10:290-295.
4. Jackson ML, Kruth SA. Immune-mediated hemolytic anemia and thrombocytopenia in the dog: A retrospective study of 55 cases diagnosed from 1969 through 1983 at the Western College of Veterinary Medicine. Can Vet J Res 1985;26:245-250.
5. Slappendel RJ. Interpretation of tests for immune-mediated blood diseases. Curr Vet Ther 1986;IX:498-505.
6. Burgess K, Moore A, Rand W, et al. Treatment of immune-mediated hemolytic anemia in dogs with cyclophosphamide. J Vet Intern Med 2000;14:456-462.
7. Klag AR, Giger U, Shofer FS. Idiopathic immune-mediated hemolytic anemia in dogs: 42 cases (1986-1990) [see comments]. J Am Vet Med Assoc 1993;202:783-788.
8. Carr AP, Panciera DL, Kidd L. Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: A retrospective study of 72 dogs. J Vet Intern Med 2002;16:504-509.
9. Weinkle TK, Center SA, Randolph JF, et al. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002). J Am Vet Med Assoc 2005;226:1869-1880.
10. Reimer ME, Troy GC, Warnick LD. Immune-mediated hemolytic anemia: 70 cases (1988-1996). J Am Anim Hosp Assoc 1999;35:384-391.
11. van den Brom WE, Biewenga WJ. Assessment of glomerular filtration rate in normal dog: Analysis of the 51Cr-EDTA clearance and its relation to several endogenous parameters of glomerular filtration. Res Vet Sci 1981;30:152-157.
12. Mason N, Duval D, Shofer FS, et al. Cyclophosphamide exerts no beneficial effect over prednisone alone in the initial treatment of acute immune-mediated hemolytic anemia in dogs: A randomized controlled clinical trial. J Vet Intern Med 2003;17: 206-212.
13. Grundy SA, Barton C. Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989-1999). J Am Vet Med Assoc 2001;218:543-546.
14. Lifton SJ. Managing immune-mediated hemolytic anemia in dogs. Vet Med 1999;94:532-546.
15. Rinkardt NE, Kruth SA. Azathioprine-induced bone marrow toxicity in four dogs. Can Vet J 1996;37:612-613.
16. Kellerman D, Bruyette D. Intravenous human immunoglobulin for the treatment of immune-mediated hemolytic anemia in 13 dogs. J Vet Intern Med 1997;11:327-332.
17. Carr AP, Panciera DL, Kidd L. Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: A retrospective study of 72 dogs. J Vet Intern Med 2002;16:504-509.
18. Klein MK, Dow SW, Rosychuk RA. Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: Ten cases (1982-1987). J Am Vet Med Assoc 1989;195:246-250.
19. Palmer KG, King LG, Van Winkle TJ. Clinical manifestations and associated disease syndromes in dogs with cranial vena cava thrombosis: 17 cases (1989-1996). J Am Vet Med Assoc 1998;213:220-224.
20. Scott-Moncrieff JC, Treadwell NG, McCullough SM, et al. Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia. J Am Anim Hosp Assoc 2001;37:220-227.
21. Johnson LR, Lappin MR, Baker DC. Pulmonary thromboembolism in 29 dogs: 1985-1995. J Vet Intern Med 1999;13:338-345.
22. Mischke R. Hemostatic disorders as a complication of auto-immune hemolytic anemia in dogs. Dtsch Tierarztl Wochenschr 1998;105:13-16.
23. Weiss DJ, Brazzell JL. Detection of activated platelets in dogs with primary immune-mediated hemolytic anemia. J Vet Intern Med 2006;20:682-686.
24. Rothuizen J, van den Brom WE. Bilirubin metabolism in canine hepatobiliary and haemolytic disease. Vet Q 1987;9:235-240.
25. Lameire N. The pathophysiology of acute renal failure. Crit Care Clin 2005;21:197-210.
26. McManus PM, Craig LE. Correlation between leukocytosis and necropsy findings in dogs with immune-mediated hemolytic anemia: 34 cases (1994-1999). J Am Vet Med Assoc 2001;218:1308-1313.
27. Janeway CA, Travers P, Walport M, Schlomchik M. Immunobiology: The Immune System in Health and Disease New York: Garland Science Publishing. 2005:85-89.